Kathleen Mary Buchheit MD
Asthma & Allergic Conditions
Associate Physician Allergy & Immunology Brigham and Women’s Hospital
Join to View Full Profile
75 Francis StBoston, MA 02115
Phone+1 617-732-9850
Fax+1 617-667-9696
Dr. Buchheit is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Brigham and Women's HospitalFellowship, Allergy and Immunology, 2013 - 2016
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2010 - 2013
Albert Einstein College of MedicineClass of 2010
Certifications & Licensure
MA State Medical License 2016 - 2026
American Board of Allergy and Immunology Allergy & Immunology
Publications & Presentations
PubMed
- Clinical efficacy and mechanisms of biologics for chronic rhinosinusitis with nasal polyps.Radomir Kratchmarov, Tiffany Dharia, Kathleen Buchheit
The Journal of Allergy and Clinical Immunology. 2025-03-23 - 2 citationsDupilumab Treatment for Aspirin-Exacerbated Respiratory Disease in a Real-World Setting: Impact on Quality of Life and Healthcare Utilization.Jyotsna Mullur, Rie Maurer, Tessa Ryan, Alanna McGill, Jillian C Bensko
American Journal of Rhinology & Allergy. 2025-03-01 - 1 citationsHuman intraepithelial mast cell differentiation and effector function are directed by TGF-β signaling.Tahereh Derakhshan, Eleanor Hollers, Alex Perniss, Tessa Ryan, Alanna McGill
The Journal of Clinical Investigation. 2025-01-02
Journal Articles
- Allergic Inflammatory Memory in Human Respiratory Epithelial Progenitor CellsNora A Barrett, Tanya M Laidlaw, Daniel F Dwyer, Joshua A Boyce, Neil Bhattacharyya, Kathleen M Buchheit, Katherine N Cahill, Nature
Authored Content
- IL-5Rα Marks Nasal Polyp IgG4 and IgE-Expressing Cells in Aspirin-Exacerbated Respiratory DiseaseMarch 2020
Press Mentions
Dupilumab Improves Outcomes in Aspirin-Exacerbated Respiratory DiseaseMay 16th, 2022
Grant Support
- Biomarkers predicting nasal polyp recurrence in aspirin-exacerbated respiratory diseaseBRIGHAM AND WOMEN'S HOSPITAL2025–2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
